Company Filing History:
1 out of 2,498 
1 out of 15,579 
Years Active: 2025
Title: Milan Stojanovic - Innovator in Molecular Detection Technologies
Introduction
Milan Stojanovic is an accomplished inventor based in Ridgewood, NJ (US). He is currently affiliated with Columbia University, where he contributes to advancements in molecular detection technologies. Despite having no granted patents to his name, his work in the field is noteworthy and impactful.
Latest Patent Applications
Milan Stojanovic has been involved in several innovative patent applications. One of his latest applications is titled "Nucleic Acid Sequences Responsive to Creatinine in Clinically Useful Ranges." This application discloses aptamers and methods for detecting a target molecule or analyte in a sample. The aptamer can include a single-stranded deoxyribonucleic acid (DNA) strand that has an oligonucleotide sequence with bases identical at least about 60% to TAATTGTGGTTCGTGTAAA (SEQ ID NO: 1). The aptamer is designed to bind the target molecule or analyte with a dissociation constant between about 10 and about 10M.
Another significant application is "Stem-Loop Receptor-Based Field-Effect Transistor Sensor Devices for Small-Molecule Target Detection Under Physiological Salt Concentrations." This application provides devices for detecting at least one target molecule in a sample. The devices comprise a field-effect transistor and an aptamer attached to the field-effect transistor. The aptamer includes a capture region and a stem region, allowing the target molecule to selectively bind to the capture region. The stem region can change the conformation of the aptamer when the capture region binds to the target molecule. Techniques for detecting a target molecule using such devices are also provided.
Conclusion
Milan Stojanovic is a dedicated inventor whose work at Columbia University focuses on innovative molecular detection technologies. His latest patent applications reflect his commitment to advancing the field, even in the absence of granted patents. His contributions are poised to make a significant impact in the realm of molecular diagnostics.